ArticleJournal of general internal medicine2024
Variation in Receipt of Cancer Screening and Immunizations by 10-year Life Expectancy among U.S. Adults aged 65 or Older in 2019.
Article in Journal of general internal medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Does Messaging for Reducing Breast Cancer Overscreening in Older Women Have Differential Responses among Medical Minimizers and Maximizers?Medical decision making : an international journal of the Society for Medical Decision Making · 2026Trial
- The effect of conflicting versus consistent messaging on older women's support for breast cancer screening cessation.Patient education and counseling · 2025Trial
- Effect of Messaging on Support for Breast Cancer Screening Cessation Among Older US Women: A Randomized Clinical Trial.JAMA network open · 2024Trial
- The perceived ethical appropriateness of messaging on breast cancer screening cessation among older women.Patient education and counseling · 2025Article
- A National Survey-Do Women 65 Years or Older Perceive Persuasion to Stop Getting Mammograms as Ethically Appropriate?Journal of general internal medicine · 2025Article
- Developing a website to help women aged 55 + incorporate risk in decision-making about breast cancer screening and prevention medications.Patient education and counseling · 2025Article
- Population attributable risk of a competing-risk model for breast cancer and non-breast cancer death among women ≥ 65 years.Breast cancer research and treatment · 2025Article
- Creating a Mammography Conversation Aid for Shared Decision-Making Between Clinicians and Women Aged 75 and Older.Journal of the American Geriatrics Society · 2025Article
- Longitudinal analysis of Annual Wellness Visit use among Medicare enrollees: Provider, enrollee, and clinic factors.Journal of the American Geriatrics Society · 2025Observational
- Why do older adults stop cancer screening? Findings from the Medicare Current Beneficiary Survey.Journal of the American Geriatrics Society · 2025Article
- Physician perspectives regarding over-screening for breast, colorectal, and prostate cancers in older adults.Journal of the American Geriatrics Society · 2025Article
- A Nationally Representative US Health and Retirement Study on Mammography Screening Use and Its Predictors Among Older Adult Women Ages 60 to 85.Breast cancer : basic and clinical research · 2025Article
- Older women's perspectives on the ethics of persuasion in doctor-patient communication.Journal of the American Geriatrics Society · 2024Article
- Examining Medical Interventions in Older Adults with Limited Life Expectancy-Opportunities and Challenges for De-implementation.Sage open agingReview
- Clinical and sociodemographic characteristics associated with health-related quality of life among older breast cancer survivors.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
importanceThe likelihood of benefit from a preventive intervention in an older adult depends on its time-to-benefit and the adult's life expectancy. For example, the time-to-benefit from cancer screening is >10 years, so adults with <10-year life expectancy are unlikely to benefit.
objectiveTo examine receipt of screening for breast, prostate, or colorectal cancer and receipt of immunizations by 10-year life expectancy.
designAnalysis of 2019 National Health Interview Survey.
participants8,329 non-institutionalized adults >65 years seen by a healthcare professional in the past year, representing 46.9 million US adults. MAIN MEASURES: Proportions of breast, prostate, and colorectal cancer screenings, and immunizations, were stratified by 10-year life expectancy, estimated using a validated mortality index. We used logistic regression to examine receipt of cancer screening and immunizations by life expectancy and sociodemographic factors. KEY
resultsOverall, 54.7% of participants were female, 41.4% were >75 years, and 76.4% were non-Hispanic White. Overall, 71.5% reported being current with colorectal cancer screening, including 61.4% of those with <10-year life expectancy. Among women, 67.0% reported a screening mammogram in the past 2 years, including 42.8% with <10-year life expectancy. Among men, 56.8% reported prostate specific antigen screening in the past two years, including 48.3% with <10-year life expectancy. Reported receipt of immunizations varied from 72.0% for influenza, 68.8% for pneumococcus, 57.7% for tetanus, and 42.6% for shingles vaccination. Lower life expectancy was associated with decreased likelihood of cancer screening and shingles vaccination but with increased likelihood of pneumococcal vaccination.
conclusionsDespite the long time-to-benefit from cancer screening, in 2019 many US adults age >65 with <10-year life expectancy reported undergoing cancer screening while many did not receive immunizations with a shorter time-to-benefit. Interventions to improve individualization of preventive care based on older adults' life expectancy may improve care of older adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.